Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Treasury Shares (2016 - 2024)

Aptevo Therapeutics' Treasury Shares history spans 9 years, with the latest figure at $83.0 for Q4 2024.

  • For Q4 2024, Treasury Shares fell 52.57% year-over-year to $83.0; the TTM value through Dec 2024 reached $83.0, down 52.57%, while the annual FY2024 figure was $83.0, 52.57% down from the prior year.
  • Treasury Shares for Q4 2024 was $83.0 at Aptevo Therapeutics, down from $175.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $223775.0 in Q4 2022 and bottomed at $83.0 in Q4 2024.
  • The 5-year median for Treasury Shares is $12355.0 (2020), against an average of $46826.5.
  • The largest annual shift saw Treasury Shares soared 531.22% in 2021 before it plummeted 99.92% in 2023.
  • A 5-year view of Treasury Shares shows it stood at $9000.0 in 2020, then skyrocketed by 531.22% to $56810.0 in 2021, then soared by 293.9% to $223775.0 in 2022, then tumbled by 99.92% to $175.0 in 2023, then crashed by 52.57% to $83.0 in 2024.
  • Per Business Quant, the three most recent readings for APVO's Treasury Shares are $83.0 (Q4 2024), $175.0 (Q4 2023), and $223775.0 (Q4 2022).